Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
Abstract Background Glioma, particularly glioblastoma (GBM), is a highly aggressive tumor with limited responsiveness to immunotherapy. PANoptosis, a form of programmed cell death merging pyroptosis, apoptosis, and necroptosis, plays an important role in reshaping the tumor microenvironment (TME) an...
Saved in:
Main Authors: | Yonghua Cai, Heng Xiao, Shuaishuai Xue, Peng Li, Zhengming Zhan, Jie Lin, Zibin Song, Jun Liu, Wei Xu, Qixiong Zhou, Songtao Qi, Xi’an Zhang, Ziyi Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-025-03301-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies
by: Liu S, et al.
Published: (2025-02-01) -
Circadian rhythm related genes signature in glioma for drug resistance prediction: a comprehensive analysis integrating transcriptomics and machine learning
by: Junbo Liao, et al.
Published: (2025-02-01) -
Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
by: Sanghee Lim, et al.
Published: (2024-04-01) -
A deep ensemble learning framework for glioma segmentation and grading prediction
by: Liang Wen, et al.
Published: (2025-02-01) -
Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma
by: Erin E. Crotty, et al.
Published: (2025-02-01)